During the past decade, Studienzentrum PD Dr. Steinwachs conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Studienzentrum PD Dr. Steinwachs" are "Alzheimer´s Disease" (2 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Studienzentrum PD Dr. Steinwachs" in a lesser frequency.

Most popular intervention types in "Studienzentrum PD Dr. Steinwachs" are "Biological" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "AFFITOPE® AD02" (1 trials), "NP031112" (1 trials), "active: AFFITOPE AD02" (1 trials) and "control: Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Studienzentrum PD Dr. Steinwachs" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Studienzentrum PD Dr. Steinwachs". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Studienzentrum PD Dr. Steinwachs, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Studienzentrum PD Dr. Steinwachs, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".